United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment normal xx large beige one (sigvaris britain ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment plus normal xx large beige one (sigvaris britain ltd -

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

United States - English - NLM (National Library of Medicine)

alembic pharmaceuticals limited - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية ابن رشد - ibn rushd drug store - aripiprazole 15 milligram - 15 milligram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment male long small charcoal (sigvaris britain ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment male long small sienna (sigvaris britain ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment male long medium charcoal (sigvaris britain ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment male long medium sienna (sigvaris britain ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

15-20mmhg) below knee closed toe lymphoedema garment male long large charcoal (sigvaris britain ltd -